THE ENDOTHELIAL L-ARGININE NITRIC-OXIDE PATHWAY AND THE RENAL CIRCULATION

被引:27
|
作者
LUSCHER, TF [1 ]
BOCK, HA [1 ]
机构
[1] UNIV BASEL KLINIKEN, KANTONSPITAL, DEPT MED, BASEL, SWITZERLAND
来源
KLINISCHE WOCHENSCHRIFT | 1991年 / 69卷 / 13期
关键词
CYCLIC GMP; ENDOTHELIUM-DERIVED RELAXING FACTOR; KIDNEY DISEASE; PLATELETS; VASODILATATION;
D O I
10.1007/BF01649323
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Endothelial cells contain an enzyme(s) which produces nitric oxide from L-arginine in response to a variety of mechanical stimuli as well as to autacoids and local and circulating hormones. Nitric oxide is a potent vasodilator and inhibitor of platelet function; it exerts its effects via activation of soluble guanylate cyclase and subsequent formation of cyclic 3'-5'-guanosine monophosphate. In the kidney, activation of the endothelial L-arginine pathway is associated with increases in renal blood flow, diuresis and natriuresis, while the glomerular filtration rate remains constant. The activity of the endothelial L-arginine pathway is impaired in hypertension and during chronic therapy with cyclosporine A. In addition, diabetes and atherosclerosis impair this pathway. Thus, the endothelial L-arginine pathway plays an important role in the local regulation of blood flow. Alterations in the activity of this pathway may play an important role in the pathophysiology of hypertension and renal disease.
引用
收藏
页码:603 / 609
页数:7
相关论文
共 50 条
  • [21] COFACTORS INVOLVED IN THE CONVERSION OF L-ARGININE TO NITRIC-OXIDE
    WHITE, KA
    HEVEL, JM
    MARLETTA, MA
    FASEB JOURNAL, 1991, 5 (04): : A787 - A787
  • [22] INHIBITION OF NITRIC-OXIDE SYNTHASE BY L-ARGININE METABOLITES
    DAS, I
    KHAN, NS
    BIOCHEMICAL SOCIETY TRANSACTIONS, 1995, 23 (02) : S324 - S324
  • [23] Modulation of the L-arginine/nitric oxide signalling pathway in vascular endothelial cells
    Wyatt, AW
    Steinert, JR
    Mann, GE
    FREE RADICALS: ENZYMOLOGY, SIGNALLING AND DISEASE, 2004, 71 : 143 - 156
  • [24] INVOLVEMENT OF THE L-ARGININE NITRIC-OXIDE PATHWAY IN INTERNAL ANAL-SPHINCTER RELAXATION
    TOTTRUP, A
    GLAVIND, EB
    SVANE, D
    GASTROENTEROLOGY, 1992, 102 (02) : 409 - 415
  • [25] ROLE OF L-ARGININE - NITRIC-OXIDE (NO) PATHWAY IN ERYTHROPOIETIN (EPO)-INDUCED HYPERTENSION(HTN)
    VAZIRI, ND
    ZHOU, XJ
    SMITH, JR
    OVEISI, F
    PURDY, RE
    FASEB JOURNAL, 1995, 9 (03): : A72 - A72
  • [26] ACTIVATION OF THE L-ARGININE NITRIC-OXIDE PATHWAY IS INVOLVED IN VASCULAR HYPOREACTIVITY INDUCED BY ENDOTOXIN
    JULOUSCHAEFFER, G
    GRAY, GA
    FLEMING, I
    SCHOTT, C
    PARRATT, JR
    STOCLET, JC
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1991, 17 : S207 - S212
  • [27] A NEW MODEL OF ISCHEMIC CARDIOMYOPATHY IN THE RAT BY INHIBITION OF THE L-ARGININE TO NITRIC-OXIDE PATHWAY
    SHUDO, H
    SAKUMA, I
    TOGASHI, H
    YOSHIOKA, M
    SAITO, H
    NAKAMURA, T
    KITABATAKE, A
    LEVI, R
    CIRCULATION, 1993, 88 (04) : 330 - 330
  • [28] NITRIC-OXIDE SYNTHESIZED FROM L-ARGININE REGULATES VASCULAR TONE IN THE CORONARY CIRCULATION OF THE RABBIT
    AMEZCUA, JL
    PALMER, RMJ
    DESOUZA, BM
    MONCADA, S
    BRITISH JOURNAL OF PHARMACOLOGY, 1989, 97 (04) : 1119 - 1124
  • [29] THE BIOLOGICAL SIGNIFICANCE OF NITRIC-OXIDE FORMATION FROM L-ARGININE
    MONCADA, S
    PALMER, RMJ
    HIGGS, EA
    BIOCHEMICAL SOCIETY TRANSACTIONS, 1989, 17 (04) : 642 - 644
  • [30] THE THERAPEUTIC USE OF L-ARGININE TO INCREASE NITRIC-OXIDE PRODUCTION
    BILLIAR, TR
    SIMMONS, R
    NUTRITION, 1992, 8 (05) : 371 - 373